AU2008297527B2 - Plants which synthesize increased amounts of glucosaminglycans - Google Patents
Plants which synthesize increased amounts of glucosaminglycans Download PDFInfo
- Publication number
- AU2008297527B2 AU2008297527B2 AU2008297527A AU2008297527A AU2008297527B2 AU 2008297527 B2 AU2008297527 B2 AU 2008297527B2 AU 2008297527 A AU2008297527 A AU 2008297527A AU 2008297527 A AU2008297527 A AU 2008297527A AU 2008297527 B2 AU2008297527 B2 AU 2008297527B2
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acid
- plant
- plants
- activity
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000000694 effects Effects 0.000 claims abstract description 192
- 238000000034 method Methods 0.000 claims abstract description 91
- 108010061048 UDPacetylglucosamine pyrophosphorylase Proteins 0.000 claims abstract description 41
- 239000000203 mixture Substances 0.000 claims abstract description 26
- 108010043841 Glucosamine 6-Phosphate N-Acetyltransferase Proteins 0.000 claims abstract description 17
- 102000002740 Glucosamine 6-Phosphate N-Acetyltransferase Human genes 0.000 claims abstract description 13
- 102100037921 UDP-N-acetylglucosamine pyrophosphorylase Human genes 0.000 claims abstract description 11
- 150000007523 nucleic acids Chemical class 0.000 claims description 310
- 108090000623 proteins and genes Proteins 0.000 claims description 249
- 102000004169 proteins and genes Human genes 0.000 claims description 234
- 108020004707 nucleic acids Proteins 0.000 claims description 210
- 102000039446 nucleic acids Human genes 0.000 claims description 210
- 239000000463 material Substances 0.000 claims description 48
- 230000008569 process Effects 0.000 claims description 41
- 238000012239 gene modification Methods 0.000 claims description 32
- 230000005017 genetic modification Effects 0.000 claims description 32
- 235000013617 genetically modified food Nutrition 0.000 claims description 32
- 238000004519 manufacturing process Methods 0.000 claims description 32
- LFTYTUAZOPRMMI-UHFFFAOYSA-N UNPD164450 Natural products O1C(CO)C(O)C(O)C(NC(=O)C)C1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-UHFFFAOYSA-N 0.000 claims description 14
- LFTYTUAZOPRMMI-CFRASDGPSA-N UDP-N-acetyl-alpha-D-glucosamine Chemical compound O1[C@H](CO)[C@@H](O)[C@H](O)[C@@H](NC(=O)C)[C@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-CFRASDGPSA-N 0.000 claims description 12
- 230000001172 regenerating effect Effects 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 37
- 238000003786 synthesis reaction Methods 0.000 abstract description 29
- 241000196324 Embryophyta Species 0.000 description 541
- 235000018102 proteins Nutrition 0.000 description 225
- 210000004027 cell Anatomy 0.000 description 175
- 229920002674 hyaluronan Polymers 0.000 description 161
- 229940099552 hyaluronan Drugs 0.000 description 141
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 141
- 108091028043 Nucleic acid sequence Proteins 0.000 description 80
- 108090000320 Hyaluronan Synthases Proteins 0.000 description 64
- 102000003918 Hyaluronan Synthases Human genes 0.000 description 63
- 102000005421 acetyltransferase Human genes 0.000 description 63
- 108020002494 acetyltransferase Proteins 0.000 description 63
- 125000003275 alpha amino acid group Chemical group 0.000 description 59
- 239000013612 plasmid Substances 0.000 description 59
- 239000013598 vector Substances 0.000 description 53
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 44
- 150000001413 amino acids Chemical class 0.000 description 43
- 238000006243 chemical reaction Methods 0.000 description 39
- 229960002897 heparin Drugs 0.000 description 39
- 210000001519 tissue Anatomy 0.000 description 34
- 229920000669 heparin Polymers 0.000 description 33
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 30
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 30
- 229920002971 Heparan sulfate Polymers 0.000 description 29
- 238000003752 polymerase chain reaction Methods 0.000 description 28
- 230000009466 transformation Effects 0.000 description 25
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 24
- 241001465754 Metazoa Species 0.000 description 23
- 108010009115 chondroitin synthase Proteins 0.000 description 23
- 108010031142 heparosan synthase Proteins 0.000 description 23
- 230000001588 bifunctional effect Effects 0.000 description 22
- 244000061456 Solanum tuberosum Species 0.000 description 21
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 20
- XHMJOUIAFHJHBW-UKFBFLRUSA-N alpha-D-glucosamine 6-phosphate Chemical compound N[C@H]1[C@@H](O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O XHMJOUIAFHJHBW-UKFBFLRUSA-N 0.000 description 20
- 229960003160 hyaluronic acid Drugs 0.000 description 20
- 108091008146 restriction endonucleases Proteins 0.000 description 20
- 230000009261 transgenic effect Effects 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 241000588724 Escherichia coli Species 0.000 description 19
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 19
- 239000012634 fragment Substances 0.000 description 18
- 238000002360 preparation method Methods 0.000 description 18
- 238000010367 cloning Methods 0.000 description 17
- 230000029087 digestion Effects 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 15
- 108020004705 Codon Proteins 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 15
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 15
- 239000013604 expression vector Substances 0.000 description 15
- 239000000178 monomer Substances 0.000 description 15
- 229920002567 Chondroitin Polymers 0.000 description 14
- 241000282414 Homo sapiens Species 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 239000000758 substrate Substances 0.000 description 14
- 108091026890 Coding region Proteins 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 13
- 238000002955 isolation Methods 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 12
- 150000002016 disaccharides Chemical group 0.000 description 12
- 241000701245 Paramecium bursaria Chlorella virus 1 Species 0.000 description 11
- 238000006555 catalytic reaction Methods 0.000 description 11
- 238000005119 centrifugation Methods 0.000 description 11
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 10
- 229920000045 Dermatan sulfate Polymers 0.000 description 10
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 10
- 240000003768 Solanum lycopersicum Species 0.000 description 10
- 241000194017 Streptococcus Species 0.000 description 10
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 10
- HDYANYHVCAPMJV-UHFFFAOYSA-N Uridine diphospho-D-glucuronic acid Natural products O1C(N2C(NC(=O)C=C2)=O)C(O)C(O)C1COP(O)(=O)OP(O)(=O)OC1OC(C(O)=O)C(O)C(O)C1O HDYANYHVCAPMJV-UHFFFAOYSA-N 0.000 description 10
- 241000700605 Viruses Species 0.000 description 10
- 230000008901 benefit Effects 0.000 description 10
- 230000002068 genetic effect Effects 0.000 description 10
- 230000010354 integration Effects 0.000 description 10
- HDYANYHVCAPMJV-USQUEEHTSA-N udp-glucuronic acid Chemical compound O([P@](O)(=O)O[P@](O)(=O)OC[C@H]1[C@@H]([C@H]([C@@H](O1)N1C(NC(=O)C=C1)=O)O)O)[C@H]1O[C@@H](C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O HDYANYHVCAPMJV-USQUEEHTSA-N 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 9
- 108091034117 Oligonucleotide Proteins 0.000 description 9
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 9
- 238000007429 general method Methods 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- 229950006780 n-acetylglucosamine Drugs 0.000 description 9
- 229920001287 Chondroitin sulfate Polymers 0.000 description 8
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 8
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 8
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 8
- 241000606856 Pasteurella multocida Species 0.000 description 8
- 240000008042 Zea mays Species 0.000 description 8
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 8
- 235000005822 corn Nutrition 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 8
- 210000004379 membrane Anatomy 0.000 description 8
- 229940051027 pasteurella multocida Drugs 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 241000701248 Chlorella virus Species 0.000 description 7
- 108010003272 Hyaluronate lyase Proteins 0.000 description 7
- 102000001974 Hyaluronidases Human genes 0.000 description 7
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 7
- 235000002595 Solanum tuberosum Nutrition 0.000 description 7
- 238000006640 acetylation reaction Methods 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 229940059329 chondroitin sulfate Drugs 0.000 description 7
- 230000007850 degeneration Effects 0.000 description 7
- 229960002442 glucosamine Drugs 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 6
- 241000195493 Cryptophyta Species 0.000 description 6
- 102000004894 Glutamine-fructose-6-phosphate transaminase (isomerizing) Human genes 0.000 description 6
- 108090001031 Glutamine-fructose-6-phosphate transaminase (isomerizing) Proteins 0.000 description 6
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 6
- 244000061176 Nicotiana tabacum Species 0.000 description 6
- YMJBYRVFGYXULK-QZABAPFNSA-N alpha-D-glucosamine 1-phosphate Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(O)=O YMJBYRVFGYXULK-QZABAPFNSA-N 0.000 description 6
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 6
- 238000004590 computer program Methods 0.000 description 6
- 229940097042 glucuronate Drugs 0.000 description 6
- 229940097043 glucuronic acid Drugs 0.000 description 6
- 229960002773 hyaluronidase Drugs 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 241000589158 Agrobacterium Species 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 5
- 241000233866 Fungi Species 0.000 description 5
- 241000606860 Pasteurella Species 0.000 description 5
- 102100024440 Phosphoacetylglucosamine mutase Human genes 0.000 description 5
- 108010074307 Phosphoacetylglucosamine mutase Proteins 0.000 description 5
- 244000062793 Sorghum vulgare Species 0.000 description 5
- 101000693115 Sulfurisphaera tokodaii (strain DSM 16993 / JCM 10545 / NBRC 100140 / 7) Sugar-1-phosphate acetyltransferase Proteins 0.000 description 5
- 108010006785 Taq Polymerase Proteins 0.000 description 5
- PGAVKCOVUIYSFO-UHFFFAOYSA-N [[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound OC1C(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-UHFFFAOYSA-N 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 108010026522 chondroitin sulfate synthase-2 Proteins 0.000 description 5
- 238000012790 confirmation Methods 0.000 description 5
- 239000005547 deoxyribonucleotide Substances 0.000 description 5
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 5
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 5
- 229940051593 dermatan sulfate Drugs 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 108010084034 glucosamine-1-phosphate acetyltransferase Proteins 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- OEANUJAFZLQYOD-CXAZCLJRSA-N (2r,3s,4r,5r,6r)-6-[(2r,3r,4r,5r,6r)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](OC)O[C@H](CO)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](OC)[C@H](C(O)=O)O1 OEANUJAFZLQYOD-CXAZCLJRSA-N 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 4
- 108010078791 Carrier Proteins Proteins 0.000 description 4
- 102000014914 Carrier Proteins Human genes 0.000 description 4
- 241000561734 Celosia cristata Species 0.000 description 4
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 4
- 102100029055 Exostosin-1 Human genes 0.000 description 4
- 108090000414 Exostosin-1 Proteins 0.000 description 4
- 108090000429 Exostosin-2 Proteins 0.000 description 4
- 241000224466 Giardia Species 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- BRGMHAYQAZFZDJ-PVFLNQBWSA-N N-Acetylglucosamine 6-phosphate Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O BRGMHAYQAZFZDJ-PVFLNQBWSA-N 0.000 description 4
- 241001520808 Panicum virgatum Species 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 235000021307 Triticum Nutrition 0.000 description 4
- PGAVKCOVUIYSFO-XVFCMESISA-N UTP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-XVFCMESISA-N 0.000 description 4
- 102000057144 Uridine Diphosphate Glucose Dehydrogenase Human genes 0.000 description 4
- 108010054269 Uridine Diphosphate Glucose Dehydrogenase Proteins 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 229940095731 candida albicans Drugs 0.000 description 4
- 210000001520 comb Anatomy 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000003306 harvesting Methods 0.000 description 4
- IAJILQKETJEXLJ-LECHCGJUSA-N iduronic acid Chemical compound O=C[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-LECHCGJUSA-N 0.000 description 4
- 230000001900 immune effect Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 201000008482 osteoarthritis Diseases 0.000 description 4
- 230000008488 polyadenylation Effects 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000012552 review Methods 0.000 description 4
- 230000001568 sexual effect Effects 0.000 description 4
- 229950010342 uridine triphosphate Drugs 0.000 description 4
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 102100029296 Chondroitin sulfate glucuronyltransferase Human genes 0.000 description 3
- 102100029305 Chondroitin sulfate synthase 3 Human genes 0.000 description 3
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 3
- 241000252212 Danio rerio Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 229920000288 Keratan sulfate Polymers 0.000 description 3
- 241000699660 Mus musculus Species 0.000 description 3
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 3
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 241001279233 Paramecium bursaria Species 0.000 description 3
- 102000016611 Proteoglycans Human genes 0.000 description 3
- 108010067787 Proteoglycans Proteins 0.000 description 3
- 240000000111 Saccharum officinarum Species 0.000 description 3
- 235000007201 Saccharum officinarum Nutrition 0.000 description 3
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 3
- 230000021736 acetylation Effects 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000000710 homodimer Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 235000019713 millet Nutrition 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 210000001938 protoplast Anatomy 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- 210000003954 umbilical cord Anatomy 0.000 description 3
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 2
- XHMJOUIAFHJHBW-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose 6-phosphate Chemical compound N[C@H]1C(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O XHMJOUIAFHJHBW-IVMDWMLBSA-N 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- 101710132601 Capsid protein Proteins 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- 241000195628 Chlorophyta Species 0.000 description 2
- GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 108010006464 Hemolysin Proteins Proteins 0.000 description 2
- 101000713575 Homo sapiens Tubulin beta-3 chain Proteins 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 244000017020 Ipomoea batatas Species 0.000 description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 description 2
- 108010044467 Isoenzymes Proteins 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- 108010046220 N-Acetylgalactosaminyltransferases Proteins 0.000 description 2
- 102000007524 N-Acetylgalactosaminyltransferases Human genes 0.000 description 2
- FZLJPEPAYPUMMR-FMDGEEDCSA-N N-acetyl-alpha-D-glucosamine 1-phosphate Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(O)=O FZLJPEPAYPUMMR-FMDGEEDCSA-N 0.000 description 2
- 101710202061 N-acetyltransferase Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 101710091688 Patatin Proteins 0.000 description 2
- 101710124951 Phospholipase C Proteins 0.000 description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 2
- 241000209056 Secale Species 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- 235000002634 Solanum Nutrition 0.000 description 2
- 241000207763 Solanum Species 0.000 description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 2
- 241000264435 Streptococcus dysgalactiae subsp. equisimilis Species 0.000 description 2
- 241000194048 Streptococcus equi Species 0.000 description 2
- 108010011834 Streptolysins Proteins 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 102100036790 Tubulin beta-3 chain Human genes 0.000 description 2
- LFTYTUAZOPRMMI-NESSUJCYSA-N UDP-N-acetyl-alpha-D-galactosamine Chemical compound O1[C@H](CO)[C@H](O)[C@H](O)[C@@H](NC(=O)C)[C@H]1O[P@](O)(=O)O[P@](O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 LFTYTUAZOPRMMI-NESSUJCYSA-N 0.000 description 2
- 235000010749 Vicia faba Nutrition 0.000 description 2
- 240000006677 Vicia faba Species 0.000 description 2
- 241000269368 Xenopus laevis Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 235000021120 animal protein Nutrition 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- BGWGXPAPYGQALX-ARQDHWQXSA-N beta-D-fructofuranose 6-phosphate Chemical compound OC[C@@]1(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O BGWGXPAPYGQALX-ARQDHWQXSA-N 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000002095 exotoxin Substances 0.000 description 2
- 231100000776 exotoxin Toxicity 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 150000002301 glucosamine derivatives Chemical class 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 239000003228 hemolysin Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 239000002417 nutraceutical Substances 0.000 description 2
- 235000021436 nutraceutical agent Nutrition 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 235000012015 potatoes Nutrition 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- BRGMHAYQAZFZDJ-UHFFFAOYSA-N (5-acetamido-3,4,6-trihydroxyoxan-2-yl)methyl dihydrogen phosphate Chemical compound CC(=O)NC1C(O)OC(COP(O)(O)=O)C(O)C1O BRGMHAYQAZFZDJ-UHFFFAOYSA-N 0.000 description 1
- 108010010888 1-aminocyclopropane-1-carboxylic acid oxidase Proteins 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241001556567 Acanthamoeba polyphaga mimivirus Species 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 101710092462 Alpha-hemolysin Proteins 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 235000021537 Beetroot Nutrition 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 235000011297 Brassica napobrassica Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 241001480010 Cestrum Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 241000777300 Congiopodidae Species 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 241000219112 Cucumis Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 235000009849 Cucumis sativus Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 229940123907 Disease modifying antirheumatic drug Drugs 0.000 description 1
- 241000255601 Drosophila melanogaster Species 0.000 description 1
- 101150111720 EPSPS gene Proteins 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 229920002444 Exopolysaccharide Polymers 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000287826 Gallus Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102100033429 Glutamine-fructose-6-phosphate aminotransferase [isomerizing] 1 Human genes 0.000 description 1
- 101710165608 Glutamine-fructose-6-phosphate aminotransferase [isomerizing] 1 Proteins 0.000 description 1
- 102100033424 Glutamine-fructose-6-phosphate aminotransferase [isomerizing] 2 Human genes 0.000 description 1
- 101710165606 Glutamine-fructose-6-phosphate aminotransferase [isomerizing] 2 Proteins 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- FUESBOMYALLFNI-VKHMYHEASA-N Gly-Asn Chemical compound NCC(=O)N[C@H](C(O)=O)CC(N)=O FUESBOMYALLFNI-VKHMYHEASA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 101150087426 Gnal gene Proteins 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- 240000008892 Helianthus tuberosus Species 0.000 description 1
- 101001035951 Homo sapiens Hyaluronan-binding protein 2 Proteins 0.000 description 1
- 101000713585 Homo sapiens Tubulin beta-4A chain Proteins 0.000 description 1
- 102100039238 Hyaluronan-binding protein 2 Human genes 0.000 description 1
- 108050009363 Hyaluronidases Proteins 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 241000227653 Lycopersicon Species 0.000 description 1
- 235000002262 Lycopersicon Nutrition 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 108030002338 N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferases Proteins 0.000 description 1
- 108010045510 NADPH-Ferrihemoprotein Reductase Proteins 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 101150040784 PAT1 gene Proteins 0.000 description 1
- 241000282516 Papio anubis Species 0.000 description 1
- 241001504519 Papio ursinus Species 0.000 description 1
- 241000223785 Paramecium Species 0.000 description 1
- 240000004370 Pastinaca sativa Species 0.000 description 1
- 235000017769 Pastinaca sativa subsp sativa Nutrition 0.000 description 1
- 101710163504 Phaseolin Proteins 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 108010068086 Polyubiquitin Proteins 0.000 description 1
- 241000282405 Pongo abelii Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000235060 Scheffersomyces stipitis Species 0.000 description 1
- 235000018704 Scorzonera hispanica Nutrition 0.000 description 1
- 244000292071 Scorzonera hispanica Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000194054 Streptococcus uberis Species 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 241000205101 Sulfolobus Species 0.000 description 1
- 241000205091 Sulfolobus solfataricus Species 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 102100036788 Tubulin beta-4A chain Human genes 0.000 description 1
- 108010082433 UDP-glucose-hexose-1-phosphate uridylyltransferase Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 108700025158 Vitreoscilla hemoglobin Proteins 0.000 description 1
- 241000269370 Xenopus <genus> Species 0.000 description 1
- 241000269457 Xenopus tropicalis Species 0.000 description 1
- 101000662549 Zea mays Sucrose synthase 1 Proteins 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- XMFDTAOKADEKJJ-IANFNVNHSA-N [2-[(3R,4R,5S,6R)-3-amino-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2-oxoethyl]phosphonic acid Chemical compound P(=O)(O)(O)CC(=O)C1(O)[C@H](N)[C@@H](O)[C@H](O)[C@H](O1)CO XMFDTAOKADEKJJ-IANFNVNHSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 208000005652 acute fatty liver of pregnancy Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 235000016520 artichoke thistle Nutrition 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 208000027720 dry mucous membrane Diseases 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 101150111330 glmU gene Proteins 0.000 description 1
- 229950010772 glucose-1-phosphate Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000008960 ketchup Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 101150015886 nuc-1 gene Proteins 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 1
- AIYJVRYFIUEBEX-FROKLYQUSA-N phosphoric acid N-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound OP(O)(O)=O.CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O AIYJVRYFIUEBEX-FROKLYQUSA-N 0.000 description 1
- 238000005293 physical law Methods 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000033339 regulation of endocytosis Effects 0.000 description 1
- 108010038196 saccharide-binding proteins Proteins 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 230000037339 smooth wrinkles Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229940115922 streptococcus uberis Drugs 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- -1 thiolate anion Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
- C12N15/8246—Non-starch polysaccharides, e.g. cellulose, fructans, levans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/06—Lysis of microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/08—Reducing the nucleic acid content
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Nutrition Science (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07116174.9 | 2007-09-12 | ||
| EP07116174A EP2036983A1 (de) | 2007-09-12 | 2007-09-12 | Pflanzen, die erhöhte Mengen an Glucosaminglycanen synthetisieren |
| US99357507P | 2007-09-13 | 2007-09-13 | |
| US60/993,575 | 2007-09-13 | ||
| PCT/EP2008/007837 WO2009033752A1 (en) | 2007-09-12 | 2008-09-11 | Plants which synthesize increased amounts of glucosaminglycans |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2008297527A1 AU2008297527A1 (en) | 2009-03-19 |
| AU2008297527B2 true AU2008297527B2 (en) | 2014-07-17 |
Family
ID=39205122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008297527A Ceased AU2008297527B2 (en) | 2007-09-12 | 2008-09-11 | Plants which synthesize increased amounts of glucosaminglycans |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9150873B2 (enExample) |
| EP (2) | EP2036983A1 (enExample) |
| JP (1) | JP5529741B2 (enExample) |
| CN (1) | CN101855354B (enExample) |
| AR (1) | AR068623A1 (enExample) |
| AT (1) | ATE551425T1 (enExample) |
| AU (1) | AU2008297527B2 (enExample) |
| CA (1) | CA2698989C (enExample) |
| WO (1) | WO2009033752A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2947597B2 (ja) | 1990-07-27 | 1999-09-13 | 日本油脂株式会社 | 鋳物加工品の塗装方法及びそれによって得られた意匠性鋳物塗装品 |
| JP5081629B2 (ja) * | 2005-12-15 | 2012-11-28 | 生化学工業株式会社 | 長鎖コンドロイチン糖鎖及びその製造方法並びにコンドロイチン合成の促進方法 |
| CN106755022B (zh) * | 2015-11-25 | 2020-08-04 | 中国科学院大连化学物理研究所 | 乙酰葡萄糖胺磷酸变位酶AtAGM编码基因及其酶、制备、应用与酶活性检测方法 |
| CN113528482B (zh) * | 2021-08-02 | 2024-02-06 | 山东大学 | 高活性肝素骨架合酶PmHS2突变体及其应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1640457A1 (de) * | 2004-09-23 | 2006-03-29 | Bayer CropScience GmbH | Verfahren und Mittel zur Herstellung von Hyaluronan |
| WO2007039314A2 (en) * | 2005-10-05 | 2007-04-12 | Bayer Cropscience Ag | Plants with increased hyaluronan production |
| WO2007039315A1 (de) * | 2005-10-05 | 2007-04-12 | Bayer Cropscience Ag | Pflanzen mit gesteigerter produktion von hyaluronan ii |
| WO2007039316A1 (en) * | 2005-10-05 | 2007-04-12 | Bayer Cropscience Ag | Improved methods and means for producings hyaluronan |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4141973A (en) * | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
| NL8300698A (nl) | 1983-02-24 | 1984-09-17 | Univ Leiden | Werkwijze voor het inbouwen van vreemd dna in het genoom van tweezaadlobbige planten; agrobacterium tumefaciens bacterien en werkwijze voor het produceren daarvan; planten en plantecellen met gewijzigde genetische eigenschappen; werkwijze voor het bereiden van chemische en/of farmaceutische produkten. |
| NO161573C (no) | 1983-11-25 | 1989-08-30 | Miles Inc | Fremgangsmaate til fremstilling av hyaluronsyre. |
| JPS60251898A (ja) * | 1984-05-25 | 1985-12-12 | Shiseido Co Ltd | 醗酵法によるヒアルロン酸の製造方法 |
| CN85100964A (zh) * | 1985-04-01 | 1988-02-17 | 赵凤源 | 树木多代嫁接繁殖法 |
| CN1003347B (zh) * | 1985-04-27 | 1989-02-22 | 广西化工研究所 | 植物生长调节剂 |
| US5565347A (en) * | 1986-06-10 | 1996-10-15 | Calgene, Inc. | Transformation and foreign gene expression with plant species |
| NO173355C (no) * | 1987-03-03 | 1993-12-01 | Chugai Pharmaceutical Co Ltd | Fremgangsm}te og selektiv bestemmelse av en h!ymolekylvekts hyaluronsyre og reagenssett for utf!relse av fremgangsm}ten |
| ES2074999T3 (es) | 1987-05-20 | 1995-10-01 | Ciba Geigy Ag | Plantas de zea mays y plantas de zea mays transgenicas regeneradas de protoplastos o celulas derivadas de protoplastos. |
| US4897349A (en) * | 1989-04-28 | 1990-01-30 | Medchem Products, Inc. | Biosynthesis of hyaluronic acid |
| US7705215B1 (en) | 1990-04-17 | 2010-04-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| DK0465875T3 (da) | 1990-06-23 | 1999-08-09 | Hoechst Schering Agrevo Gmbh | Fremgangsmåde til produktion af en calluskultur af Zea mays (L.) |
| JPH05199877A (ja) | 1991-10-03 | 1993-08-10 | Sumitomo Chem Co Ltd | バレイショおよびイネの誘導型植物防御遺伝子の制御領域、その用途およびアッセイ法 |
| US6455304B1 (en) * | 1994-07-01 | 2002-09-24 | The Board Of Regents Of The University Of Oklahoma | Hyaluronate synthase gene and uses thereof |
| IT1271001B (it) | 1994-07-26 | 1997-05-26 | Poli Ind Chimica Spa | Procedimento di preparazione di acido ialuronico mediante fermentazione con streptococcus |
| DE19619918A1 (de) * | 1996-05-17 | 1997-11-20 | Planttec Biotechnologie Gmbh | Nucleinsäuremoleküle codierend lösliche Stärkesynthasen aus Mais |
| GB9702592D0 (en) | 1997-02-07 | 1997-03-26 | Danisco | Selection method |
| US6369298B1 (en) * | 1997-04-30 | 2002-04-09 | Pioneer Hi-Bred International, Inc. | Agrobacterium mediated transformation of sorghum |
| US20030104601A1 (en) * | 1999-04-01 | 2003-06-05 | Deangelis Paul L. | Chondroitin synthase gene and methods of making and using same |
| US7094581B2 (en) * | 1998-10-26 | 2006-08-22 | The Board Of Regents Of The University Of Oklahoma | Hyaluronan synthases and methods of making and using same |
| JP2001060708A (ja) * | 1999-06-18 | 2001-03-06 | Nippon Sheet Glass Co Ltd | 透明積層体およびこれを用いたガラス物品 |
| AR044724A1 (es) | 2000-03-27 | 2005-10-05 | Syngenta Participations Ag | Promotores del virus de la rizadura amarilla del cestrum |
| US6607745B2 (en) * | 2001-05-18 | 2003-08-19 | Harry Leneau | Ingestion of hyaluronic acid for improved joint function and health |
| JP4702819B2 (ja) * | 2001-08-01 | 2011-06-15 | 生化学工業株式会社 | コンドロイチン合成酵素 |
| JP4101548B2 (ja) * | 2001-08-10 | 2008-06-18 | 生化学工業株式会社 | コンドロイチン合成酵素及びそれをコードするｄｎａ |
| US7811806B2 (en) * | 2001-12-21 | 2010-10-12 | Novozymes, Inc. | Methods for producing hyaluronan in a recombinant host cell |
| US20040003432A1 (en) * | 2002-05-06 | 2004-01-01 | Pharmacia Corporation | Production of hexosamines and uses thereof |
| DE60324797D1 (de) * | 2002-05-31 | 2009-01-02 | Seikagaku Kogyo Co Ltd | Chondroitinsynthetase und das enzym codierende dna |
| ES2354696T3 (es) * | 2003-07-31 | 2011-03-17 | Toyo Boseki Kabushiki Kaisha | Planta que produce ácido hialurónico. |
| PT1805312E (pt) * | 2004-09-23 | 2009-09-28 | Bayer Cropscience Ag | Processos e meios para produzir hialurano |
| BRPI0614885A2 (pt) * | 2005-08-25 | 2011-04-19 | Toyo Boseki | planta produtora de ácido hialurÈnico |
| AU2006298964B2 (en) * | 2005-10-05 | 2013-05-02 | Bayer Intellectual Property Gmbh | Plants having an increased content of amino sugars |
-
2007
- 2007-09-12 EP EP07116174A patent/EP2036983A1/de not_active Withdrawn
-
2008
- 2008-09-11 CA CA2698989A patent/CA2698989C/en not_active Expired - Fee Related
- 2008-09-11 JP JP2010524414A patent/JP5529741B2/ja not_active Expired - Fee Related
- 2008-09-11 CN CN200880115486.6A patent/CN101855354B/zh not_active Expired - Fee Related
- 2008-09-11 AT AT08802357T patent/ATE551425T1/de active
- 2008-09-11 EP EP08802357A patent/EP2190998B1/en not_active Not-in-force
- 2008-09-11 WO PCT/EP2008/007837 patent/WO2009033752A1/en not_active Ceased
- 2008-09-11 US US12/733,613 patent/US9150873B2/en not_active Expired - Fee Related
- 2008-09-11 AU AU2008297527A patent/AU2008297527B2/en not_active Ceased
- 2008-09-12 AR ARP080103967A patent/AR068623A1/es unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1640457A1 (de) * | 2004-09-23 | 2006-03-29 | Bayer CropScience GmbH | Verfahren und Mittel zur Herstellung von Hyaluronan |
| WO2007039314A2 (en) * | 2005-10-05 | 2007-04-12 | Bayer Cropscience Ag | Plants with increased hyaluronan production |
| WO2007039315A1 (de) * | 2005-10-05 | 2007-04-12 | Bayer Cropscience Ag | Pflanzen mit gesteigerter produktion von hyaluronan ii |
| WO2007039316A1 (en) * | 2005-10-05 | 2007-04-12 | Bayer Cropscience Ag | Improved methods and means for producings hyaluronan |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010538626A (ja) | 2010-12-16 |
| CA2698989A1 (en) | 2009-03-19 |
| ATE551425T1 (de) | 2012-04-15 |
| CN101855354B (zh) | 2016-04-06 |
| EP2190998B1 (en) | 2012-03-28 |
| US9150873B2 (en) | 2015-10-06 |
| JP5529741B2 (ja) | 2014-06-25 |
| CN101855354A (zh) | 2010-10-06 |
| AU2008297527A1 (en) | 2009-03-19 |
| EP2036983A1 (de) | 2009-03-18 |
| WO2009033752A1 (en) | 2009-03-19 |
| US20100196966A1 (en) | 2010-08-05 |
| AR068623A1 (es) | 2009-11-25 |
| CA2698989C (en) | 2018-07-24 |
| EP2190998A1 (en) | 2010-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1951030B1 (en) | Improved methods and means for producings hyaluronan | |
| AU2006298961B2 (en) | Plants with increased hyaluronan production | |
| US20080250533A1 (en) | Plants With an Increased Production of Hyaluronan II | |
| US9376507B2 (en) | Methods and means for the manufacturing of hyaluronan | |
| AU2008297527B2 (en) | Plants which synthesize increased amounts of glucosaminglycans | |
| JP5210165B2 (ja) | 増加したアミノ糖含量を有する植物 | |
| DK1951878T3 (en) | Plants with increased hyaluronanproduktion | |
| AU2013201153B2 (en) | Improved Methods and Means for Producing Hyaluronan | |
| CN101277610B (zh) | 用于产生乙酰透明质酸的改良的方法和手段 | |
| DK1951030T3 (en) | IMPROVED METHODS AND MEANS FOR THE PRODUCTION OF hyaluronan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| PC | Assignment registered |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH Free format text: FORMER OWNER WAS: BAYER CROPSCIENCE AG |
|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |